KSQ Therapeutics

The ambition to cure

Lexington, United States · Founded 2015 · $156.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Website
ksqtx.com
Total Funding
$156.0M
Last Round
$80.0M Series CSep 2018
Rounds
2

About

KSQ Therapeutics is a clinical-stage biotechnology company headquartered in Lexington, Massachusetts. Founded in 2015 and backed by Flagship Pioneering, KSQ has industrialized genome-wide CRISPR/Cas9 functional genomic screens (CRISPRomics platform) across cancer models and immune cell types to identify high-confidence therapeutic targets. The company's lead programs are eTIL (engineered Tumor-Infiltrating Lymphocyte) therapies, which knock out SOCS1 and Regnase-1 targets to dramatically boost T cell tumor-killing activity. KSQ has strategic partnerships with Takeda, Ono, and Roche for immuno-oncology programs, and has raised over $156M in funding. The company is advancing multiple eTIL candidates including KSQ-001EX and KSQ-004EX.

Summary

KSQ Therapeutics is a Biotech company based in Lexington, United States, founded in 2015. It has raised $156.0M in total across 2 rounds, most recently a $80.0M Series C round in Sep 2018. Investors include Baillie Gifford, Cowen Healthcare Investments and Invus.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2018
$80.0M

Sign up to see all 2 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KSQ Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ksq-therapeutics"><img src="https://indexed.vc/api/badge/company/ksq-therapeutics" alt="KSQ Therapeutics on Indexed.vc" width="260" height="76" /></a>